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Background: The advantages of proximal resection with jejunal
interposition and modified D2 lymphadenectomy, for elderly
patients, could outweigh the higher risk of recurrence with this
less radical lymphadenectomy. The aim of our study was to eval-
uate proximal resection with modified D2 lymphadenectomy as
an alternative in selected patients.
Methods: Between 1993 and 2009, 161 patients at our centre
had surgery for adenocarcinoma of the proximal third of the
stomach. Patients were divided into three groups: (1) PG, proximal
resection with jejunal interposition and modified D2 lymphade-
nectomy (19.3%, 31 patients); (2) TH, transhiatal extended total
gastrectomy with resection of the distal oesophagus and D2 lym-
phadenectomy (23.6%, 38 patients); (3) GT, total gastrectomy with
D2 lymphadenectomy (57.1%, 92 patients). We analysed postoper-
ative morbidity, 30-day mortality, and survival. Quality of life was
evaluated with the gastrointestinal quality-of-life index (GIQLI)
questionnaire.
Findings: Patients in the PG group (79.4 ± 9 years) were signifi-
cantly older than the patients in the GT (63.9 ± 11 years) or TH
group (60.1 ± 12 years; p < 0.0001), and in worse general condition.
Fewer lymph nodes were harvested in the PG group (17.2 ± 11)
than in the GT and TH groups (24.05 ± 13 and 26.3 ± 13). There
were no significant differences in the distribution of pathohisto-
logical characteristics and tumour TNM stages between groups.
An R0 resection could be done in 77.2–86.8% of cases. 30-day mor-
tality was 9.7% in the PG group, 6.5% in GT, and 5.3% in TH. There
were no differences in morbidity and 5-year survival between
groups (25.3% in PG, 26.3% in GT, and 28.9% in TH). No differences
were found in the total scores of the GIQLI questionnaire
(p = 0.893). Patients in the PG group had the lowest scores in diges-
tive functions.
Interpretation: Proximal resection should be reserved for high-
risk elderly patients with proximal gastric cancer, who have
shorter expected long-term survival. These resections carry
acceptable morbidity and mortality; however, reconstruction with
jejunal interposition does not bring the desired functional
benefits.
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Background: Chemotherapy-induced neutropenia, a toxic effect
of systemic chemotherapy, is often associated with substantial
mortality and morbidity; thus, identifying its related determi-
nants is necessary. The aim of this study was to identify the main
consequences of severe neutropenia following adjuvant chemo-
therapy, in a community-based population of patients with can-
cer in Iran-Semnan.
Methods: This prospective study included 828 consecutive
patients who received chemotherapy for histologically proven
primary or metastatic solid tumours. Demographics data, disease
characteristics, and comorbidities (including current smoking
and diabetes) were collected from interviews with the patients
and their laboratory data and files. Patients had a complete blood
count 1 week after the first course of chemotherapy.
Findings: Based on the absolute neutrophil count nadir value,
30 patients (3.6%) had severe neutropenia. Multivariable
logistic-regression analysis showed that advanced age (OR =
5.262, p = 0.012) and diabetes mellitus (OR = 8.126, p = 0.015) were
main determinants of severe neutropenia, with the presence
of demographic characteristics and comorbidities as
confounders.
Interpretation: We identified advanced age and diabetes as
main determinants of high-grade neutropenia in Iranian patients
with solid tumours who were receiving adjuvant chemotherapy.
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Background: Total thyroidectomy and central neck dissection
are the procedures of choice for patients with medullary thyroid
carcinoma (MTC). We reviewed patients with advanced MTC
who underwent surgical treatment, to discuss the clinical out-
comes and prognostic factors.
Methods: 132 patients had total or subtotal thyroidectomy with
central neck dissection. Ipsilateral (n = 96) and bilateral (n = 36)
modified radical neck dissection was done simultaneously, in
patients with and without evidence of suspicious lymph nodes.
After surgery, basal and stimulated serum calcitonins (Cts) were
measured in all patients. Follow-up ranged between 5 and 12.5
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